Remodeling of the Core Leads HIV-1 Preintegration Complex into the Nucleus of Human Lymphocytes.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
18 05 2020
Historique:
received: 24 01 2020
accepted: 24 03 2020
pubmed: 3 4 2020
medline: 21 10 2020
entrez: 3 4 2020
Statut: epublish

Résumé

Retroviral replication proceeds through obligate integration of the viral DNA into the host genome. In particular, for the HIV-1 genome to enter the nucleus, it must be led through the nuclear pore complex (NPC). During the HIV-1 cytoplasmic journey, the viral core acts as a shell to protect the viral genetic material from antiviral sensors and ensure an adequate environment for reverse transcription. However, the relatively narrow size of the nuclear pore channel requires that the HIV-1 core is reshaped into a structure that fits the pore. On the other hand, the organization of the viral CA proteins that remain associated with the preintegration complex (PIC) during and after nuclear translocation is still enigmatic. In this study, we analyzed the progressive organizational changes of viral CA proteins within the cytoplasm and the nucleus by immunogold labeling. Furthermore, we set up a novel technology, HIV-1 ANCHOR, which enables the specific detection of the retrotranscribed DNA by fluorescence microscopy, thereby offering the opportunity to uncover the architecture of the potential HIV-1 PIC. Thus, we combined the immunoelectron microscopy and ANCHOR technologies to reveal the presence of DNA- and CA-positive complexes by correlated light and electron microscopy (CLEM). During and after nuclear translocation, HIV-1 appears as a complex of viral DNA decorated by multiple viral CA proteins remodeled in a pearl necklace-like shape. Thus, we could describe how CA proteins are reshaped around the viral DNA to permit the entrance of the HIV-1 in the nucleus. This particular CA protein complex composed of the integrase and the retrotranscribed DNA leads the HIV-1 genome inside the host nucleus. Our findings contribute to the understanding of the early steps of HIV-1 infection and provide new insights into the organization of HIV-1 CA proteins during and after viral nuclear entry. Of note, we are now able to visualize the viral DNA in viral complexes, opening up new perspectives for future studies on virus's fate in the cell nucleus.

Identifiants

pubmed: 32238582
pii: JVI.00135-20
doi: 10.1128/JVI.00135-20
pmc: PMC7269431
pii:
doi:

Substances chimiques

Multiprotein Complexes 0
HIV Integrase EC 2.7.7.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 Blanco-Rodriguez et al.

Références

Virol J. 2020 Jan 7;17(1):4
pubmed: 31910871
J Virol. 2018 Sep 12;92(19):
pubmed: 29997211
Genes Dev. 2014 Jun 1;28(11):1228-38
pubmed: 24829297
Am J Anat. 1989 Jun-Jul;185(2-3):264-70
pubmed: 2476021
J Mol Biol. 1994 Sep 2;241(5):651-62
pubmed: 7520946
J Virol. 2006 Apr;80(8):3712-20
pubmed: 16571788
PLoS Pathog. 2013;9(6):e1003461
pubmed: 23818857
Elife. 2019 Jan 23;8:
pubmed: 30672737
Nat Rev Microbiol. 2015 Aug;13(8):471-83
pubmed: 26179359
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8869-73
pubmed: 9671771
Microsc Res Tech. 2004 Sep;65(1-2):33-42
pubmed: 15570586
Proc Natl Acad Sci U S A. 2017 Aug 22;114(34):E7169-E7178
pubmed: 28784755
Cell Rep. 2015 Nov 24;13(8):1717-31
pubmed: 26586435
PLoS Pathog. 2013;9(10):e1003693
pubmed: 24130490
Nature. 2013 Oct 24;502(7472):559-62
pubmed: 24048477
PLoS Genet. 2014 Mar 13;10(3):e1004187
pubmed: 24625580
Nat Immunol. 2010 Nov;11(11):1005-13
pubmed: 20871604
J Virol. 2017 Apr 13;91(9):
pubmed: 28250118
PLoS Pathog. 2012;8(8):e1002896
pubmed: 22956906
Cell Host Microbe. 2018 Apr 11;23(4):536-548.e6
pubmed: 29649444
Cell Host Microbe. 2010 Mar 18;7(3):221-33
pubmed: 20227665
Nature. 2011 Jan 20;469(7330):424-7
pubmed: 21248851
PLoS Pathog. 2014 Oct 30;10(10):e1004459
pubmed: 25356722
Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9975-80
pubmed: 21628558
J Virol. 2016 May 27;90(12):5808-5823
pubmed: 27076642
J Biol Chem. 2010 Dec 10;285(50):39314-28
pubmed: 20937817
Elife. 2014 Dec 17;3:e04114
pubmed: 25517934
Mol Biol Cell. 2002 Feb;13(2):425-34
pubmed: 11854401
J Virol. 2000 Aug;74(15):7119-26
pubmed: 10888652
J Virol. 2004 Jun;78(11):5670-8
pubmed: 15140964
Retrovirology. 2016 Apr 23;13:28
pubmed: 27107820
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E1054-63
pubmed: 26858452
Cell. 2007 Dec 14;131(6):1059-71
pubmed: 18083097
Microsc Res Tech. 2007 Feb;70(2):135-46
pubmed: 17133410
Nat Protoc. 2007;2(10):2480-91
pubmed: 17947990
PLoS Pathog. 2017 Aug 21;13(8):e1006570
pubmed: 28827840
PLoS One. 2012;7(9):e46037
pubmed: 23049930
Science. 1999 Jan 1;283(5398):80-3
pubmed: 9872746
J Virol. 2012 May;86(10):5931-6
pubmed: 22398280
Nature. 2016 Aug 18;536(7616):349-53
pubmed: 27509857
J Virol. 2001 Aug;75(16):7683-91
pubmed: 11462040
J Virol. 2018 Aug 29;92(18):
pubmed: 29997215
Elife. 2018 Jun 07;7:
pubmed: 29877795
Nat Med. 2001 May;7(5):631-4
pubmed: 11329067
J Struct Biol. 2014 Mar;185(3):278-84
pubmed: 24300554
Nat Med. 2019 Sep;25(9):1377-1384
pubmed: 31501601
J Virol. 1997 Aug;71(8):5871-7
pubmed: 9223476
Virology. 2013 May 25;440(1):8-18
pubmed: 23523133
Nat Methods. 2017 Jan 31;14(2):102-103
pubmed: 28139674
J Struct Biol. 2005 Oct;152(1):36-51
pubmed: 16182563
Nature. 2013 Nov 21;503(7476):402-405
pubmed: 24196705
Science. 2014 Jul 11;345(6193):179-83
pubmed: 24968937
J Virol. 1997 Jul;71(7):5382-90
pubmed: 9188609
Nat Nanotechnol. 2013 Feb;8(2):130-6
pubmed: 23334171
J Virol. 2020 Mar 17;94(7):
pubmed: 31941774
Nat Commun. 2015 Mar 06;6:6483
pubmed: 25744187
Nat Struct Mol Biol. 2004 Jul;11(7):672-5
pubmed: 15208690
PLoS Pathog. 2016 Jun 20;12(6):e1005709
pubmed: 27322072
J Virol. 2018 Aug 29;92(18):
pubmed: 29950406
Nature. 2004 Feb 26;427(6977):848-53
pubmed: 14985764
J Cell Biol. 2002 Nov 11;159(3):441-52
pubmed: 12417576
Science. 2016 Dec 16;354(6318):1434-1437
pubmed: 27980210
Cell Syst. 2015 Aug 26;1(2):163-73
pubmed: 27135801
PLoS Pathog. 2011 Aug;7(8):e1002194
pubmed: 21901095
Nature. 2015 May 14;521(7551):227-31
pubmed: 25731161
PLoS Pathog. 2011 Dec;7(12):e1002439
pubmed: 22174692
Viruses. 2018 May 19;10(5):
pubmed: 29783762
Nat Commun. 2017 Dec 1;8(1):1882
pubmed: 29192235
Cell Host Microbe. 2018 Sep 12;24(3):392-404.e8
pubmed: 30173955
Nat Methods. 2012 Jun 28;9(7):690-6
pubmed: 22743774
J Struct Biol. 2014 May;186(2):273-82
pubmed: 24704216
J Struct Biol. 1996 Jan-Feb;116(1):71-6
pubmed: 8742726

Auteurs

Guillermo Blanco-Rodriguez (G)

Department of Virology, VMV, Institut Pasteur, Paris, France.
Ecole Doctorale Frontiere de l'Innovation en Recherche et Education, CRI 75004, Université de Paris, Paris, France.

Anastasia Gazi (A)

Unit for Service and Technology in Ultra-Structural Bio-Imaging, Center for Resources and Research in Technology, Pasteur Institute, Paris, France.

Blandine Monel (B)

Department of Virology, UVI, Pasteur Institute, Paris, France.

Stella Frabetti (S)

Department of Virology, VMV, Institut Pasteur, Paris, France.

Viviana Scoca (V)

Department of Virology, VMV, Institut Pasteur, Paris, France.

Florian Mueller (F)

Département Biologie Cellulaire et Infections, UIM, Pasteur Institute, Paris, France.
C3BI, USR 3756 IP CNRS, Paris, France.

Olivier Schwartz (O)

Department of Virology, UVI, Pasteur Institute, Paris, France.

Jacomine Krijnse-Locker (J)

Unit for Service and Technology in Ultra-Structural Bio-Imaging, Center for Resources and Research in Technology, Pasteur Institute, Paris, France.
Paul Ehrlich Institute, Langen, Germany.

Pierre Charneau (P)

Department of Virology, VMV, Institut Pasteur, Paris, France.

Francesca Di Nunzio (F)

Department of Virology, VMV, Institut Pasteur, Paris, France dinunzio@pasteur.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH